TSBP1

gene
On this page

Also known as TSBP

Summary

TSBP1 (testis expressed basic protein 1, HGNC:13922) is a protein-coding gene on chromosome 6p21.32, encoding Testis-expressed basic protein 1 (Q5SRN2).

Located in nucleus.

Source: NCBI Gene 10665 — RefSeq curated summary.

At a glance

  • GWAS associations: 137
  • Clinical variants (ClinVar): 6 total
  • MANE Select transcript: NM_001286474

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13922
Approved symbolTSBP1
Nametestis expressed basic protein 1
Location6p21.32
Locus typegene with protein product
StatusApproved
AliasesTSBP
Ensembl geneENSG00000204296
Ensembl biotypeprotein_coding
OMIM618151
Entrez10665

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 8 protein_coding

ENST00000375015, ENST00000442822, ENST00000447241, ENST00000527965, ENST00000532023, ENST00000533191, ENST00000534588, ENST00000698834

RefSeq mRNA: 3 — MANE Select: NM_001286474 NM_001286474, NM_001286475, NM_006781

CCDS: CCDS34422, CCDS69082, CCDS75430

Canonical transcript exons

ENST00000413045 — 0 exons

Expression profiles

Bgee: expression breadth broad, 58 present calls, max score 89.77.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0437 / max 33.8314, expressed in 3 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
729450.02443
729460.01343
729440.00593

Top tissues by expression

94 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453389.77gold quality
testisUBERON:000047389.33gold quality
right testisUBERON:000453488.88gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.10gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099177.51gold quality
sural nerveUBERON:001548855.74gold quality
lymph nodeUBERON:000002952.50gold quality
bone marrow cellCL:000209247.96gold quality
colonic epitheliumUBERON:000039746.68gold quality
calcaneal tendonUBERON:000370146.04silver quality
adrenal tissueUBERON:001830345.37gold quality
tonsilUBERON:000237244.36silver quality
uterine cervixUBERON:000000242.99silver quality
right ovaryUBERON:000211842.45silver quality
ventricular zoneUBERON:000305342.31gold quality
ovaryUBERON:000099241.35gold quality
cortical plateUBERON:000534341.27gold quality
endometriumUBERON:000129540.74gold quality
left ovaryUBERON:000211939.71gold quality
endocervixUBERON:000045839.43gold quality
ganglionic eminenceUBERON:000402339.03gold quality
bone marrowUBERON:000237138.91gold quality
body of uterusUBERON:000985338.12silver quality
metanephros cortexUBERON:001053335.71silver quality
apex of heartUBERON:000209835.45gold quality
ectocervixUBERON:001224935.24silver quality
tibial nerveUBERON:000132335.13gold quality
vermiform appendixUBERON:000115435.12gold quality
granulocyteCL:000009434.99gold quality
duodenumUBERON:000211434.79gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.41

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

27 targeting TSBP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-7162-3P99.8968.161682
HSA-MIR-430799.8270.453374
HSA-MIR-467999.7669.191229
HSA-MIR-129099.5969.902079
HSA-MIR-516B-5P99.5666.331495
HSA-MIR-450599.2767.812678
HSA-MIR-578799.2267.862628
HSA-MIR-6506-5P99.0465.661386
HSA-MIR-4738-3P98.9867.981846
HSA-MIR-6761-5P98.7168.031504
HSA-MIR-6830-3P98.6268.071760
HSA-MIR-619-5P98.5764.971988
HSA-MIR-3689A-5P98.3570.121049
HSA-MIR-3689B-5P98.3570.121049
HSA-MIR-3689E98.3570.121049
HSA-MIR-3689F98.3570.081052
HSA-MIR-508798.0169.09965
HSA-MIR-446898.0166.851187
HSA-MIR-5681A97.9967.171658
HSA-MIR-15B-3P97.8566.68974
HSA-MIR-365297.7165.431890
HSA-MIR-443097.4765.611813
HSA-MIR-6500-3P97.4267.20867
HSA-MIR-227897.3066.191130
HSA-MIR-4474-3P96.9765.87870

Literature-anchored findings (GeneRIF, showing 4)

  • Our findings suggest that CpG-single nucleotide polymorphisms at the C6orf10/LOC101929163 locus might modify age of onset in C9orf72 carriers belonging to the entire amyotrophic lateral sclerosis-frontotemporal dementia spectrum by controlling DNA methylation and gene expression (PMID:30252044)
  • Shared Signature of Recent Positive Selection on the TSBP1-BTNL2-HLA-DRA Genes in Five Native Populations from North Borneo. (PMID:33022050)
  • Multilocus evaluation of genetic predictors of multiple sclerosis. (PMID:34656742)
  • Impact of missense TSBP1 variants on the susceptibility to coronary heart disease. (PMID:38042215)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusTsbp1ENSMUSG00000057246
rattus_norvegicusTsbp1ENSRNOG00000039398

Protein

Protein identifiers

Testis-expressed basic protein 1Q5SRN2 (reviewed: Q5SRN2)

Alternative names: Uncharacterized protein C6orf10

All UniProt accessions (7): A0A1U9X7D1, A0A8V8TNR9, C9J9T8, E9PLW3, E9PNQ4, E9PQ85, Q5SRN2

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Isoforms (3)

UniProt IDNamesCanonical?
Q5SRN2-11yes
Q5SRN2-22
Q5SRN2-33

RefSeq proteins (3): NP_001273403, NP_001273404, NP_006772 (=MANE)

Domains & families (InterPro)

IDNameType
IPR038754TSBP1Family

UniProt features (28 total): sequence variant 14, compositionally biased region 5, splice variant 4, transmembrane region 2, region of interest 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5SRN2-F145.580.04

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 33 (showing top): IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM, KRAS.600.LUNG.BREAST_UP.V1_DN, KRAS.BREAST_UP.V1_DN, KRAS.LUNG.BREAST_UP.V1_DN, ZNF146_TARGET_GENES, MIR4505, MIR5787, MIR5681A, FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON, TTCYRGAA_UNKNOWN, DESCARTES_FETAL_MUSCLE_SCHWANN_CELLS, FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN, GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN, GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN, GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (2): nucleus (GO:0005634), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
intracellular membrane-bounded organelle1
cellular anatomical structure1

Protein interactions and networks

STRING

354 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TSBP1BTNL2Q9UIR0697
TSBP1TTC32Q5I0X7591
TSBP1MICBP79525539
TSBP1COL11A2P13942531
TSBP1NOTCH4Q99466527
TSBP1HLA-DRAP01903507
TSBP1HLA-DRB1P01911505
TSBP1HLA-DQB1P01917479
TSBP1PSORS1C1Q9UIG5471
TSBP1E7ENX8E7ENX8448
TSBP1Q5Y7H0Q5Y7H0446
TSBP1TNFP01375432
TSBP1BRD2P25440429
TSBP1RNF5Q99942417
TSBP1TNXBP22105417

IntAct

2 interactions, top by confidence:

ABTypeScore
ARHGAP18CLTBpsi-mi:“MI:0914”(association)0.350

BioGRID (6): C6orf10 (Biochemical Activity), C6orf10 (Affinity Capture-MS), C6orf10 (Cross-Linking-MS (XL-MS)), C6orf10 (Cross-Linking-MS (XL-MS)), C6orf10 (Affinity Capture-MS), C6orf10 (Proximity Label-MS)

ESM2 similar proteins: A0A060XQP6, A0A1S4FQ37, A2VD23, A3KQQ9, A7E371, B3A0Q3, B3EWZ0, B3EWZ1, B3EWZ4, B7W112, D1FQ14, E9Q9K5, G5EC21, O01949, O16883, O43493, O46203, O55188, O84462, P08721, P10451, P10923, P13665, P14287, P19814, P23498, P31096, P31097, P31098, P31936, P35662, P35663, P98193, Q13316, Q14093, Q28139, Q5MIT9, Q5SRN2, Q5UQ32, Q62313

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

6 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance2
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2509 predictions. Top by Δscore:

VariantEffectΔscore
6:32335910:A:ACdonor_gain1.0000
6:32335911:C:CCdonor_gain1.0000
6:32337187:T:TAdonor_gain1.0000
6:32300701:C:CCacceptor_gain0.9900
6:32302607:A:ACdonor_gain0.9900
6:32302608:C:CCdonor_gain0.9900
6:32302628:TCCTG:Tacceptor_loss0.9900
6:32302629:CCTGA:Cacceptor_loss0.9900
6:32302630:CTG:Cacceptor_loss0.9900
6:32331958:TAA:Tdonor_gain0.9900
6:32331959:AAA:Adonor_gain0.9900
6:32331960:A:Cdonor_gain0.9900
6:32335933:C:CCacceptor_gain0.9900
6:32355648:C:CTdonor_gain0.9900
6:32300678:A:ACdonor_gain0.9800
6:32300679:C:CCdonor_gain0.9800
6:32302608:CTA:Cdonor_gain0.9800
6:32302631:T:Aacceptor_loss0.9800
6:32331959:A:ACdonor_gain0.9800
6:32335907:CT:Cdonor_loss0.9800
6:32335908:TT:Tdonor_loss0.9800
6:32335911:C:CTdonor_loss0.9800
6:32355647:A:ACdonor_gain0.9800
6:32369896:CCA:Cdonor_gain0.9800
6:32302608:CTAG:Cdonor_gain0.9700
6:32335933:CTGTG:Cacceptor_loss0.9700
6:32335934:T:Gacceptor_loss0.9700
6:32335935:G:Cacceptor_gain0.9700
6:32335935:G:GCacceptor_gain0.9700
6:32355678:A:Cacceptor_gain0.9700

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000007662 (6:32351023 T>A,C), RS1000067287 (6:32321111 G>GT), RS1000078036 (6:32371552 A>G), RS1000129903 (6:32371298 C>T), RS1000132775 (6:32334966 G>A), RS1000138973 (6:32322811 C>T), RS1000144699 (6:32350561 G>T), RS1000184669 (6:32332383 A>G), RS1000329283 (6:32342630 A>G), RS1000381928 (6:32342351 C>T), RS1000420138 (6:32320830 C>T), RS1000440099 (6:32335267 A>G), RS1000492815 (6:32309701 G>T), RS1000602977 (6:32297980 T>A), RS1000659344 (6:32348647 C>G)

Disease associations

OMIM: gene MIM:618151 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

137 associations (top):

StudyTraitp-value
GCST000180_4Bone mineral density (spine)1.000000e-07
GCST000408_6Primary biliary cholangitis1.000000e-10
GCST000408_7Primary biliary cholangitis7.000000e-10
GCST000624_3Ulcerative colitis9.000000e-23
GCST000981_1Vitiligo8.000000e-11
GCST000984_17Idiopathic membranous nephropathy2.000000e-40
GCST000984_4Idiopathic membranous nephropathy5.000000e-71
GCST000996_22Systemic lupus erythematosus3.000000e-06
GCST001183_6Asthma3.000000e-15
GCST001459_1Multiple sclerosis7.000000e-16
GCST001525_5Visceral fat3.000000e-06
GCST001574_8Activated partial thromboplastin time7.000000e-07
GCST001587_6Coronary heart disease3.000000e-15
GCST001709_7Atopic dermatitis5.000000e-19
GCST001762_369Obesity-related traits2.000000e-06
GCST001815_1Hepatitis C induced liver cirrhosis9.000000e-11
GCST001942_21Prostate cancer5.000000e-09
GCST002097_4Coronary artery calcification3.000000e-06
GCST002217_4Sjögren’s syndrome9.000000e-37
GCST002297_1Hepatitis B vaccine response3.000000e-19
GCST002300_1Rheumatoid arthritis3.000000e-12
GCST002479_16Lupus nephritis in systemic lupus erythematosus2.000000e-06
GCST002737_3Atopic dermatitis4.000000e-08
GCST003450_2Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia3.000000e-09
GCST003773_15Loneliness (multivariate analysis)2.000000e-06
GCST004122_3Fibrinogen levels9.000000e-09
GCST004131_25Inflammatory bowel disease2.000000e-31
GCST004133_79Ulcerative colitis5.000000e-65
GCST004521_1Autism spectrum disorder or schizophrenia2.000000e-16
GCST004521_10Autism spectrum disorder or schizophrenia2.000000e-13

EFO canonical traits (19, from GWAS)

EFO IDTrait name
EFO:0004267biliary liver cirrhosis
EFO:0003939energy intake
EFO:0004723coronary artery calcification
EFO:0004645response to vaccine
EFO:0007865loneliness measurement
EFO:0007788BMI-adjusted waist-hip ratio
EFO:0008002physical activity measurement
EFO:0007986reticulocyte count
EFO:0004587lymphocyte count
EFO:0008377mosquito bite reaction itch intensity measurement
EFO:0008378mosquito bite reaction size measurement
EFO:0009180rosacea severity measurement
EFO:0004808L lactate dehydrogenase measurement
EFO:0006336diastolic blood pressure
EFO:0004509hemoglobin measurement
EFO:0009819comparative body size at age 10, self-reported
EFO:0004918age at diagnosis
EFO:0008039BMI-adjusted hip circumference
EFO:0007789BMI-adjusted waist circumference

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

10 total (human), top 10 by PubMed support.

ChemicalActions (top 5)PubMed papers
Silicon Dioxidedecreases expression2
bisphenol Aaffects methylation1
butyraldehydedecreases expression1
aflatoxin B2increases methylation1
Grape Seed Proanthocyanidinsaffects cotreatment, decreases expression1
Arsenicaffects methylation1
Benzo(a)pyrenedecreases expression1
Catechinaffects cotreatment, decreases expression1
Diethylhexyl Phthalatedecreases expression1
Tetrachlorodibenzodioxindecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.